Patents by Inventor Diana Boraschi

Diana Boraschi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5922573
    Abstract: DNA molecules that code for IL-1 antagonists with improved biological activity arc described. DNA molecules coding for improved IL-1 antagonists inserted into expression vectors and host cells transformed with the said vectors containing the DNA coding for improved IL-1 antagonists and a method for the production of improved IL-1 antagonists in essentially pure form are also described. Preparations that can be injected or can be administered by some other route, consisting of a pharmaceutical preparation of the said mutants, are particularly useful as drugs in the field of therapy.
    Type: Grant
    Filed: April 15, 1997
    Date of Patent: July 13, 1999
    Assignee: Dompe' S.p.A.
    Inventors: Diana Boraschi, Paola Bossu, Paolo Ruggiero, Giovanni Macchia, Aldo Tagliabue, Francesco Frigerio, Renata Grifantini, Gianni Frascotti, Guido Grandi
  • Patent number: 5206014
    Abstract: The specification relates to a synthetic peptide converted into a salt comprising one or more amine groups and capable of potentiating in vivo the primary and secondary antibody response to thymo-dependent and thymo-independent antigens having low immunogenicity.Injectable preparations comprising a solution of the peptide in a pharmacologically acceptable solvent are particularly useful as adjuvants in therapy.
    Type: Grant
    Filed: February 12, 1988
    Date of Patent: April 27, 1993
    Assignee: Sclavo, S.p.A.
    Inventors: Luciano Nencioni, Guido Antoni, Diana Boraschi, Aldo Tagliabue
  • Patent number: 4816560
    Abstract: New partially retro-inverted tuftsin analogues of general formula I ##STR1## wherein R represents the side-chain of the amino acids threonine, methionine or leucineR.sup.1 represents the side-chain of the amino acids lysine or arginineR.sup.2 is hydrogen or a metabolically labile acyl group,all the asymmetric carbon atoms are either of the S- or R-configuration, or, alternatively, the first, third, and fourth asymmetric carbons, starting from the N-terminal residue, are of the S-configuration while the second one is of the R- or (R,S)-configuration, and the corresponding pharmacologically acceptable salts, esters and amides. The new compounds which share the same pharmacological properties of tuftsin, are much more stable toward the enzymatic degradation than the parent molecule.
    Type: Grant
    Filed: July 16, 1987
    Date of Patent: March 28, 1989
    Assignees: Eniricerche S.p.A., Sclavo S.p.A.
    Inventors: Antonio S. Verdini, Fabio Bonelli, Antonello Pessi, Franco Cardinali, Diana Boraschi, Stefano Censini, Romano Di Trapani
  • Patent number: 4774320
    Abstract: Synthetic peptide with human interleukin 1 activity, which peptide can be used as a stimulant of the immune functions and can be defined by the general formula:Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys-X (I)where: Val=L-valine; Gln=L-glutamine; Gly=glycine; Glu=L-glutamic acid; Ser=L-serine; Asn=L-asparagine; Asp=L-aspartic acid; Lys=L-lysine; X=cysteine (Cys), OH, NH.sub.2, a benzyl ester or an alkyl ester group having a number of carbon atoms from 1 to 7.
    Type: Grant
    Filed: October 20, 1986
    Date of Patent: September 27, 1988
    Assignee: Sclavo S.p.A.
    Inventors: Aldo Tagliabue, Guido Antoni, Rivo Presentini, Diana Boraschi